NDC 31722-580

Maraviroc

Maraviroc

Maraviroc is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is Maraviroc.

Product ID31722-580_d6904ba1-cfd4-b9e4-e053-2a95a90a1106
NDC31722-580
Product TypeHuman Prescription Drug
Proprietary NameMaraviroc
Generic NameMaraviroc
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2022-02-06
Marketing CategoryANDA /
Application NumberANDA203347
Labeler NameCamber Pharmaceuticals, Inc.
Substance NameMARAVIROC
Active Ingredient Strength300 mg/1
Pharm ClassesCCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 31722-580-60

60 TABLET, FILM COATED in 1 BOTTLE (31722-580-60)
Marketing Start Date2022-02-06
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Maraviroc" or generic name "Maraviroc"

NDCBrand NameGeneric Name
31722-579MaravirocMaraviroc
31722-580MaravirocMaraviroc
49702-223SELZENTRYmaraviroc
49702-224SELZENTRYmaraviroc
49702-233SELZENTRYmaraviroc
49702-235SELZENTRYmaraviroc
49702-237SELZENTRYmaraviroc
49702-260SELZENTRYmaraviroc
50090-1486SELZENTRYmaraviroc
50090-6238SELZENTRYmaraviroc

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.